Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1991 1
1992 1
1994 1
1998 4
1999 5
2000 1
2002 1
2003 1
2004 1
2005 6
2006 3
2007 2
2008 1
2009 3
2010 5
2011 1
2012 3
2014 1
2015 1
2017 1
2021 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

40 results

Results by year

Filters applied: . Clear all
Page 1
Ca(2+) release-activated Ca(2+) channel inhibitors.
Pevarello P, Cainarca S, Liberati C, Tarroni P, Piscitelli F, Severi E. Pevarello P, et al. Pharm Pat Anal. 2014 Mar;3(2):171-82. doi: 10.4155/ppa.14.7. Pharm Pat Anal. 2014. PMID: 24588594 Review.
P2X7 antagonists for CNS indications: recent patent disclosures.
Pevarello P, Bovolenta S, Tarroni P, Za L, Severi E, Torino D, Vitalone R. Pevarello P, et al. Pharm Pat Anal. 2017 Mar;6(2):61-76. doi: 10.4155/ppa-2016-0044. Epub 2017 Mar 1. Pharm Pat Anal. 2017. PMID: 28248151 Review.
FFA4/GPR120 agonists: a survey of the recent patent literature.
Formicola R, Pevarello P, Kuhn C, Liberati C, Piscitelli F, Sodano M. Formicola R, et al. Among authors: pevarello p. Pharm Pat Anal. 2015;4(6):443-51. doi: 10.4155/ppa.15.33. Pharm Pat Anal. 2015. PMID: 26580993 Review.
Ion channel blockers for the treatment of neuropathic pain.
Colombo E, Francisconi S, Faravelli L, Izzo E, Pevarello P. Colombo E, et al. Among authors: pevarello p. Future Med Chem. 2010 May;2(5):803-42. doi: 10.4155/fmc.10.19. Future Med Chem. 2010. PMID: 21426204 Review.
IP issues facing researchers by Gino D'Oca.
Almarsson O, Angiolini M, Baell J, Giardina G, Ingham A, Hughes A, Pevarello P, Sindelar R. Almarsson O, et al. Among authors: pevarello p. Pharm Pat Anal. 2012 May;1(2):129-35. doi: 10.4155/ppa.12.15. Pharm Pat Anal. 2012. PMID: 24236778
CDK inhibitors in cancer therapy: what is next?
Malumbres M, Pevarello P, Barbacid M, Bischoff JR. Malumbres M, et al. Among authors: pevarello p. Trends Pharmacol Sci. 2008 Jan;29(1):16-21. doi: 10.1016/j.tips.2007.10.012. Epub 2007 Dec 4. Trends Pharmacol Sci. 2008. PMID: 18054800
40 results